Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
Manuela
M
Krause
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
Anna
A
Henningsen
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
Antje
A
Torge
Center of Blood Transfusion, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
David
D
Juhl
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
Ralf
R
Junker
Thrombosis Unit, National Hemophilia Center, Tel Hashomer and the Sackler Medical School, Tel Aviv University, Israel.
Gili
G
Kenet
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
Dorothee
D
Kowalski
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
Verena
V
Limperger
Department of Medicine/Hematology & Oncology, Univ. Hospital of Münster, Germany.
Rolf
R
Mesters
Department of Anesthesiology and Intensive Care Medicine, Charité - Universitäts-medizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany.
Anonymous
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
Angela
A
Rocke
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
Maria
M
Shneyder
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
Hartmut
H
Clausnizer
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
Hanna
H
Schiesewitz
Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany. Electronic address: leagottl@uksh.de.
Ulrike
U
Nowak-Göttl
D000293:Adolescent; D000328:Adult; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069552:Rivaroxaban / Q000009:adverse effects / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000188:drug therapy*; D055815:Young Adult
D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban